Analyst Ratings For RCUS – Arcus Biosciences (NYSE:RCUS)
Today, Leerink Swann initiated coverage on RCUS – Arcus Biosciences (NYSE:RCUS) with a Outperform with a price target of $14.34.
Some recent analyst ratings include
- 4/9/2018-Leerink Swann initiated coverage with a Outperform rating.
- 4/9/2018-Citigroup initiated coverage with a Buy rating.
- 4/9/2018-Goldman Sachs initiated coverage with a Neutral rating.
Recent Trading Activity for RCUS – Arcus Biosciences (NYSE:RCUS)
Shares of RCUS – Arcus Biosciences closed the previous trading session at 14.20 down -0.14 0.98% with 14.5 shares trading hands.